Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months

Published:2021-02-05 Issue:7 Volume:62 Page:1639-1647
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Rajamäki Aino¹²^ORCID,Sunela Kaisa³,Prusila Roosa E. I.⁴,Kuusisto Milla E. L.⁴⁵,Mercadal Santiago⁶,Selander Tuomas⁷,Kuitunen Hanne⁸,Pollari Marjukka³,Jantunen Esa²⁹¹⁰,Nystrand Ilja¹¹,Sancho Juan-Manuel¹²,Sorigue Marc¹²,Kuittinen Outi²⁴¹³

Affiliation:

1. Department of Oncology, Central Finland Central Hospital, Jyväskylä, Finland

2. Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland

3. Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere, Finland

4. Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland

5. Department of Haematology, Oulu University Hospital, Oulu, Finland

6. ICO-Hospital Duran I Reynals, L’Hospitalet, Spain

7. Science Service Center, Kuopio University Hospital, Kuopio, Finland

8. Department of Oncology, Oulu University Hospital, Oulu, Finland

9. Department of Medicine, Kuopio University Hospital, Kuopio, Finland

10. Department of Medicine, North Carelia Central Hospital, Joensuu, Finland

11. Research Program Unit, Medical Faculty, University of Helsinki, Finland

12. Department of Hematology, ICO-Hospital Germans Trias i Pujol, Functional cytomics-IJC, Badalona, Spain

13. Department of Oncology, Kuopio University Hospital, Kuopio, Finland

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1872073

Reference33 articles.

1. Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study

2. Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience

3. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience

4. Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs

5. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice;Acta Oncologica;2024-05-06

2. Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden;HemaSphere;2023-02-23

3. Should PRIMA Prognostic Index Be Widely Applied Instead of FLIPI2 in the Prognosis of Follicular Lymphoma?;Clinical Cancer Investigation Journal;2023

4. Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020;British Journal of Haematology;2022-12-13

5. Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study;Blood Cancer Journal;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3